Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2003 Mar;79(929):154–158. doi: 10.1136/pmj.79.929.154

Management of irritable bowel syndrome

M Gunn 1, A Cavin 1, J Mansfield 1
PMCID: PMC1742653  PMID: 12697915

Full Text

The Full Text of this article is available as a PDF (90.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal A., Cutts T. F., Abell T. L., Cardoso S., Familoni B., Bremer J., Karas J. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 1994 Apr;106(4):945–950. doi: 10.1016/0016-5085(94)90753-6. [DOI] [PubMed] [Google Scholar]
  2. Bharucha A. E., Camilleri M., Low P. A., Zinsmeister A. R. Autonomic dysfunction in gastrointestinal motility disorders. Gut. 1993 Mar;34(3):397–401. doi: 10.1136/gut.34.3.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bouras E. P., Camilleri M., Burton D. D., Thomforde G., McKinzie S., Zinsmeister A. R. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001 Feb;120(2):354–360. doi: 10.1053/gast.2001.21166. [DOI] [PubMed] [Google Scholar]
  4. Camilleri M., Heading R. C., Thompson W. G. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther. 2002 Aug;16(8):1407–1430. doi: 10.1046/j.1365-2036.2002.01305.x. [DOI] [PubMed] [Google Scholar]
  5. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology. 2001 Feb;120(3):652–668. doi: 10.1053/gast.2001.21908. [DOI] [PubMed] [Google Scholar]
  6. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology. 2001 Feb;120(3):652–668. doi: 10.1053/gast.2001.21908. [DOI] [PubMed] [Google Scholar]
  7. Camilleri M., Williams D. E. Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures. Pharmacoeconomics. 2000 Apr;17(4):331–338. doi: 10.2165/00019053-200017040-00003. [DOI] [PubMed] [Google Scholar]
  8. Cann P. A., Read N. W., Holdsworth C. D. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut. 1984 Feb;25(2):168–173. doi: 10.1136/gut.25.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Corney R. H., Stanton R. Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res. 1990;34(5):483–491. doi: 10.1016/0022-3999(90)90022-v. [DOI] [PubMed] [Google Scholar]
  10. De Ponti F., Tonini M. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs. 2001;61(3):317–332. doi: 10.2165/00003495-200161030-00001. [DOI] [PubMed] [Google Scholar]
  11. Degen L., Matzinger D., Merz M., Appel-Dingemanse S., Osborne S., Lüchinger S., Bertold R., Maecke H., Beglinger C. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther. 2001 Nov;15(11):1745–1751. doi: 10.1046/j.1365-2036.2001.01103.x. [DOI] [PubMed] [Google Scholar]
  12. Delvaux M., Denis P., Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility. Eur J Gastroenterol Hepatol. 1997 Apr;9(4):345–352. doi: 10.1097/00042737-199704000-00006. [DOI] [PubMed] [Google Scholar]
  13. Drossman D. A., Leserman J., Nachman G., Li Z. M., Gluck H., Toomey T. C., Mitchell C. M. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 1990 Dec 1;113(11):828–833. doi: 10.7326/0003-4819-113-11-828. [DOI] [PubMed] [Google Scholar]
  14. Drossman D. A., Li Z., Andruzzi E., Temple R. D., Talley N. J., Thompson W. G., Whitehead W. E., Janssens J., Funch-Jensen P., Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep;38(9):1569–1580. doi: 10.1007/BF01303162. [DOI] [PubMed] [Google Scholar]
  15. Drossman D. A., Whitehead W. E., Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997 Jun;112(6):2120–2137. doi: 10.1053/gast.1997.v112.agast972120. [DOI] [PubMed] [Google Scholar]
  16. Farthing M. J. Irritable bowel, irritable body, or irritable brain? BMJ. 1995 Jan 21;310(6973):171–175. doi: 10.1136/bmj.310.6973.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Farthing M. J. New drugs in the management of the irritable bowel syndrome. Drugs. 1998 Jul;56(1):11–21. doi: 10.2165/00003495-199856010-00002. [DOI] [PubMed] [Google Scholar]
  18. Francis C. Y., Duffy J. N., Whorwell P. J., Martin D. F. Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol. 1996 Jul;91(7):1348–1350. [PubMed] [Google Scholar]
  19. Francis C. Y., Whorwell P. J. Bran and irritable bowel syndrome: time for reappraisal. Lancet. 1994 Jul 2;344(8914):39–40. doi: 10.1016/s0140-6736(94)91055-3. [DOI] [PubMed] [Google Scholar]
  20. Frayling I. M. Microsatellite instability. Gut. 1999 Jul;45(1):1–4. doi: 10.1136/gut.45.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gwee K. A., Graham J. C., McKendrick M. W., Collins S. M., Marshall J. S., Walters S. J., Read N. W. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet. 1996 Jan 20;347(8995):150–153. doi: 10.1016/s0140-6736(96)90341-4. [DOI] [PubMed] [Google Scholar]
  22. Gwee K. A., Leong Y. L., Graham C., McKendrick M. W., Collins S. M., Walters S. J., Underwood J. E., Read N. W. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999 Mar;44(3):400–406. doi: 10.1136/gut.44.3.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Heaton K. W., O'Donnell L. J., Braddon F. E., Mountford R. A., Hughes A. O., Cripps P. J. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology. 1992 Jun;102(6):1962–1967. doi: 10.1016/0016-5085(92)90320-x. [DOI] [PubMed] [Google Scholar]
  24. Jailwala J., Imperiale T. F., Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med. 2000 Jul 18;133(2):136–147. doi: 10.7326/0003-4819-133-2-200007180-00013. [DOI] [PubMed] [Google Scholar]
  25. Jones J., Boorman J., Cann P., Forbes A., Gomborone J., Heaton K., Hungin P., Kumar D., Libby G., Spiller R. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut. 2000 Nov;47 (Suppl 2):ii1–i19. doi: 10.1136/gut.47.suppl_2.ii1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jones R., Lydeard S. Irritable bowel syndrome in the general population. BMJ. 1992 Jan 11;304(6819):87–90. doi: 10.1136/bmj.304.6819.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jones V. A., McLaughlan P., Shorthouse M., Workman E., Hunter J. O. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet. 1982 Nov 20;2(8308):1115–1117. doi: 10.1016/s0140-6736(82)92782-9. [DOI] [PubMed] [Google Scholar]
  28. Klein K. B. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology. 1988 Jul;95(1):232–241. doi: 10.1016/0016-5085(88)90319-8. [DOI] [PubMed] [Google Scholar]
  29. Longstreth G. F., Preskill D. B., Youkeles L. Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy. Relation to gynecologic features and outcome. Dig Dis Sci. 1990 Oct;35(10):1285–1290. doi: 10.1007/BF01536421. [DOI] [PubMed] [Google Scholar]
  30. MacIntosh D. G., Thompson W. G., Patel D. G., Barr R., Guindi M. Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol. 1992 Oct;87(10):1407–1409. [PubMed] [Google Scholar]
  31. Manning A. P., Thompson W. G., Heaton K. W., Morris A. F. Towards positive diagnosis of the irritable bowel. Br Med J. 1978 Sep 2;2(6138):653–654. doi: 10.1136/bmj.2.6138.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mitchell S. A., Mee A. S., Smith G. D., Palmer K. R., Chapman R. W. Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial. Aliment Pharmacol Ther. 2002 Jun;16(6):1187–1195. doi: 10.1046/j.1365-2036.2002.01277.x. [DOI] [PubMed] [Google Scholar]
  33. Neal K. R., Hebden J., Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997 Mar 15;314(7083):779–782. doi: 10.1136/bmj.314.7083.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Olden Kevin W. Diagnosis of irritable bowel syndrome. Gastroenterology. 2002 May;122(6):1701–1714. doi: 10.1053/gast.2002.33741. [DOI] [PubMed] [Google Scholar]
  35. Olden Kevin W. Diagnosis of irritable bowel syndrome. Gastroenterology. 2002 May;122(6):1701–1714. doi: 10.1053/gast.2002.33741. [DOI] [PubMed] [Google Scholar]
  36. Owens D. M., Nelson D. K., Talley N. J. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med. 1995 Jan 15;122(2):107–112. doi: 10.7326/0003-4819-122-2-199501150-00005. [DOI] [PubMed] [Google Scholar]
  38. Payne A., Blanchard E. B. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. J Consult Clin Psychol. 1995 Oct;63(5):779–786. doi: 10.1037//0022-006x.63.5.779. [DOI] [PubMed] [Google Scholar]
  39. Prather C. M., Camilleri M., Zinsmeister A. R., McKinzie S., Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology. 2000 Mar;118(3):463–468. doi: 10.1016/s0016-5085(00)70251-4. [DOI] [PubMed] [Google Scholar]
  40. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut. 1973 Feb;14(2):125–132. doi: 10.1136/gut.14.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Suarez F. L., Savaiano D. A., Levitt M. D. A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med. 1995 Jul 6;333(1):1–4. doi: 10.1056/NEJM199507063330101. [DOI] [PubMed] [Google Scholar]
  42. Talley N. J., Gabriel S. E., Harmsen W. S., Zinsmeister A. R., Evans R. W. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995 Dec;109(6):1736–1741. doi: 10.1016/0016-5085(95)90738-6. [DOI] [PubMed] [Google Scholar]
  43. Talley N. J., O'Keefe E. A., Zinsmeister A. R., Melton L. J., 3rd Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology. 1992 Mar;102(3):895–901. doi: 10.1016/0016-5085(92)90175-x. [DOI] [PubMed] [Google Scholar]
  44. Talley N. J., Owen B. K., Boyce P., Paterson K. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol. 1996 Feb;91(2):277–283. [PubMed] [Google Scholar]
  45. Talley N. J., Zinsmeister A. R., Melton L. J., 3rd Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995 Jul 1;142(1):76–83. doi: 10.1093/oxfordjournals.aje.a117548. [DOI] [PubMed] [Google Scholar]
  46. Talley Nicholas J., Spiller Robin. Irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002 Aug 17;360(9332):555–564. doi: 10.1016/S0140-6736(02)09712-X. [DOI] [PubMed] [Google Scholar]
  47. Talley Nicholas J., Spiller Robin. Irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002 Aug 17;360(9332):555–564. doi: 10.1016/S0140-6736(02)09712-X. [DOI] [PubMed] [Google Scholar]
  48. Thompson W. G., Heaton K. W., Smyth G. T., Smyth C. Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol. 1997 Jul;9(7):689–692. doi: 10.1097/00042737-199707000-00008. [DOI] [PubMed] [Google Scholar]
  49. Thompson W. G. The treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2002 Aug;16(8):1395–1406. doi: 10.1046/j.1365-2036.2002.01312.x. [DOI] [PubMed] [Google Scholar]
  50. Whitehead W. E., Holtkotter B., Enck P., Hoelzl R., Holmes K. D., Anthony J., Shabsin H. S., Schuster M. M. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990 May;98(5 Pt 1):1187–1192. doi: 10.1016/0016-5085(90)90332-u. [DOI] [PubMed] [Google Scholar]
  51. Whitehead W. E., Winget C., Fedoravicius A. S., Wooley S., Blackwell B. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci. 1982 Mar;27(3):202–208. doi: 10.1007/BF01296915. [DOI] [PubMed] [Google Scholar]
  52. Williams A. J., Merrick M. V., Eastwood M. A. Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment. Gut. 1991 Sep;32(9):1004–1006. doi: 10.1136/gut.32.9.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. van der Horst H. E., van Dulmen A. M., Schellevis F. G., van Eijk J. T., Fennis J. F., Bleijenberg G. Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut. 1997 Nov;41(5):669–674. doi: 10.1136/gut.41.5.669. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES